BioScale, a manufacturer of protein measurement technology, disclosed in SEC filings that it raised $5. 2 million convertible debt 37 separate investors participated in the bid
BioScale was founded in 2002 by Mark Lundstrom, CEO, and three interdisciplinary MIT professors. Since then, the Company has put together a development, engineering, manufacturing and industrially seasoned commercial team to launch its AMMP assay technology and ViBE platform globally in the pharmaceutical, biotech, life sciences and bioprocess markets. We are also pursuing partnerships for diagnostic and specialty applications The company’s new 30,000 square Uh, ft Global headquarters and manufacturing facilities are located in Lexington, Massachusetts.
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/BioScale/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
